Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.

被引:6
|
作者
Grivas, Petros [1 ,2 ]
Barata, Pedro C. [3 ]
Moon, Helen H. [4 ]
Gupta, Shilpa [5 ]
Hutson, Thomas E. [6 ]
Sternberg, Cora N. [7 ]
Brown, Jason [8 ]
Dave, Vaidehi [9 ]
Downey, Chad [10 ]
Shillington, Alicia C. [11 ]
Katzenstein, Howard [12 ]
Kirker, Melissa
Hanson, Sarah
Liu, Frank X.
Morris, Valerie A.
Bhanegaonkar, Abhijeet
Sonpavde, Guru P.
机构
[1] Univ Washington, Div Hematol & Oncol, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, Seattle, WA USA
[3] Univ Hosp Seidman, Canc Ctr, Cleveland, OH USA
[4] Kaiser Permanente, Riverside, CA USA
[5] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA
[6] Texas Oncol, Dallas, TX USA
[7] Weill Cornell Med, Hematol Oncol, New York, NY USA
[8] RTI Hlth Solut, Res Triangle Pk, NC USA
[9] EPI Q Inc, Oak Brook, IL USA
[10] EMD Serono, Rockland, MA USA
[11] Pfizer, New York, NY USA
[12] AdventHlth Med Grp, Orlando, FL USA
关键词
261-492-3532-2370-7650-2700; 283-183-138-12268; 130-231; 261-492-11294; 261-492-3532-2370; 613-135-244-3829; 5; 4; 3; 2; 1880; 62; 295; 1;
D O I
10.1200/JCO.2024.42.4_suppl.697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:697 / 697
页数:1
相关论文
共 50 条
  • [1] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [2] Baseline characteristics from a retrospective, observational, US-based, multicenter, real-world (RW) study of avelumab first-line maintenance (1LM) in locally advanced/metastatic urothelial carcinoma (la/mUC) (PATRIOT-II).
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen
    Hutson, Thomas E.
    Gupta, Shilpa
    Sternberg, Cora N.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Devgan, Geeta
    Kirker, Melissa
    Thakkar, Sheena
    Katzenstein, Howard M.
    Bhanegaonkar, Abhijeet
    Liu, Frank
    Brown, Jason
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
    Park, Se Hoon
    Shin, Sang Joon
    Rha, Sun Young
    Beom, Seung-Hoon
    Seo, Ho Kyung
    Keam, Bhumsuk
    Kim, Miso
    Hong, Yoon-Hee
    Yoon, Shinkyo
    Lee, Jae-Lyun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [4] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    Mansinho, Andre
    Cruz, Andreia
    Marconi, Lorenzo
    Pinto, Cidalia
    Augusto, Isabel
    ADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150
  • [5] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    André Mansinho
    Andreia Cruz
    Lorenzo Marconi
    Cidália Pinto
    Isabel Augusto
    Advances in Therapy, 2023, 40 : 4134 - 4150
  • [6] Maintenance therapy with avelumab as the first-line treatment in patients with metastatic urothelial carcinoma: A real-world, ambispective RAVE-Bladder study.
    Gridneva, Yana
    Sultanbaev, Alexander, Sr.
    Anzhiganova, Yulia
    Gluzman, Mark
    Mochalova, Anastasia
    Shkurat, Alexey
    Parsadanova, Elvira
    Israelyan, Edgar
    Murzina, Yulia
    Kalpinsky, Aleksey
    Stativko, Olesia
    Karabina, Elena
    Kfln, Artyom
    Petkau, Vladislav
    Tovbik, Natalya
    Turganova, Maria
    Safina, Sufiia
    Kopyltsov, Evgeny
    Volkova, Maria
    Tsimafeyeu, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Alicia, K. Morgans
    Guru, P. Sonpavde
    Vanessa, Shih
    Phoebe, Wright
    Zsolt, Hepp
    Candice, L. Willmon
    Nancy, Chang
    Steven, Sesterhenn
    Boppudi, Naga Sai Sriteja
    Thomas, Powles
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S26 - S27
  • [8] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [9] Avelumab first-line maintenance (1LM) for locally advanced or metastatic urothelial carcinoma (la/mUC): Treatment (tx) patterns and real-world (rw) outcomes in the US
    Carson, K.
    Mahmoudpour, H.
    Ike, C.
    Monzon, S.
    Fragkogianni, S.
    Ferrer, J.
    Kearney, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1215 - S1216
  • [10] Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia
    Moujaber, Tania
    Tran Ben
    Liow, Elizabeth
    Clay, Timothy
    Bennett, Geer
    Kearney, Mairead
    Gibberd, Alison
    Gurney, Howard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 94 - 95